Skip to main content

MS Lifelines Patient Support Program

EMD Serono

UnknownUnder review·Mar 20, 2026

The MS Lifelines Patient Support Program is associated with Mavenclad, a drug for Multiple Sclerosis, and is likely offered by its manufacturer, EMD Serono. While typically offering support to patients with MS, without page content, it's unclear if this particular grant provides direct travel assistance or what specific services it covers for patients taking or considering Mavenclad.

Covers
transportation
Enrollment cycle
unknown

Eligibility

Eligibility is restricted to adults with relapsing forms of multiple sclerosis who have typically tried and failed other MS treatments. Applicants must be residents of the United States and should not have certain contraindications like active cancer, HIV, or pregnancy.

Status source

unclear if this particular grant provides direct travel assistance or what specific services it covers